Olema Pharmaceuticals, Inc. (OLMA)
24.70
+0.34
(+1.40%)
USD |
NASDAQ |
Feb 24, 16:00
24.70
0.00 (0.00%)
After-Hours: 16:14
Olema Pharmaceuticals Research and Development Expense (Quarterly) : 39.95M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Cidara Therapeutics, Inc. | 35.53M |
| Cogent Biosciences, Inc. | 74.38M |
| Corvus Pharmaceuticals, Inc. | 8.454M |
| BridgeBio Pharma, Inc. | 112.87M |
| Oric Pharmaceuticals, Inc. | 28.77M |